Acomplia is Waiting For The Test For Time in The UK and EU
Acomplia (Rimonabant) was approved for sale in the UK on June which means the introduction of this drug is new. Acomplia has not yet got FDA (Food and Drug Administration) approval for sale in the US. Sanofi-Aventis is the manufacturer of Acomplia, which is a French pharmaceutical firm. The drug is prescribed for suppressing appetite in an obese person. The suppression of appetite helps in lowering calorie intake thereby reducing obesity. During its trial period the manufacturer also claimed of this drug having smoking cessation effect.
As the introduction of this drug is new the success of this drug remains to be seen. But the real problem is the availability of the drug. At present only a few numbers of pharmacies are keeping it with them as FDA has not approved its use as a weight loss pill. Till the moment when FDA approves the drug, the pharmacies in US would be having tough time assuring the customers of its arrival soon.
The clinical results of Acomplia (Rimonabant) for 2 years showed much promise for this new weight loss drug. In the clinical trials around 40% of the sample lost 10% or more...
To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...
